论文部分内容阅读
目的 :评价长江流域6城市医院喹诺酮类药物的利用情况及发展趋势。方法 :对长江流域6城市156家医院喹诺酮类药物的应用品种、购药金额和用药频度 (DDDs)等进行统计分析。结果 :2000年～2003年156家医院喹诺酮类药物购药金额、DDDs和限定日费用的年平均增长率分别为22. 08 %、2 .16 %和19. 50 % ,特别是高限定日费用的注射用药物增长速度较快 ,其用药金额和DDDs年平均增长率达到33. 22 %和33. 59 % ,而口服喹诺酮类药物相应的增长率仅为8. 57 %和—0. 88 %。左氧氟沙星位于购药金额的第1位 ,占喹诺酮类药物总金额的48. 22 % ,其DDDs占喹诺酮类药物总DDDs的25. 66 %。结论 :喹诺酮类药物的市场将继续扩大。
Objective: To evaluate the utilization status and development trend of quinolones in 6 city hospitals in the Yangtze valley. Methods: The quinolones used in 156 hospitals in 6 cities of 6 cities in the Yangtze River valley were analyzed for their application varieties, the amount of drugs purchased and the DDDs. Results: The average annual growth rates of quinolone drug purchase amount, DDDs and daily limit-fee for 156 hospitals from 2000 to 2003 were 22. 08%, 2.16% and 19. 50% respectively, especially the high fixed daily expenses Of the injecting drugs grew faster, the amount of their medication and the average annual growth rate of DDDs reached 33. 22% and 33. 59%, while the corresponding rate of oral quinolones increased by only 8. 57% and -0 88% . 66%. Levofloxacin is located in the first purchase amount of money, accounting for 48.22% of the total amount of quinolones, DDDs accounted for 25.66% of the total DDDs quinolones. Conclusion: The market for quinolones will continue to expand.